Rescheduling ketamine under the Misuse of Drugs Regulations 2001
This consultation seeks your views on the Advisory Council on the Misuse of Drugs’ (ACMD) recommendation to reschedule ketamine to Schedule 2 to the Misuse of Drugs Regulations 2001 (as amended) (the 2001 Regulations).
This follows reclassification under the Misuse of Drugs Act 1971 (the 1971 Act) as a Class B drug on 10 June 2014, more specifically on the record keeping, prescribing and safe custody requirements applicable to Schedule 2 drugs.
Ketamine is currently a Schedule 4 Part 1 drug and therefore lightly regulated.
These proposals have been prepared in discussion with the ACMD and the Department of Health.
0%
1.
Options
Page 1 of 6
There was an error on your page. Please correct any required fields and submit again.
Go to the first error.
Please read the full consultation document before beginning this survey.
1.
In light of the risks of diversion from legitimate uses and the harms identified in the ACMD advice, which option do you support?
Option 1: Do nothing
Option 2: Full Schedule 2 status under the 2001 Regulations as recommended by the ACMD
Option 3: Full Schedule 3 status under the 2001 Regulations
Option 4: Schedule 3 status, but with exemption from the safe custody requirements
Please explain why (maximum 100 words)
Javascript Required
Javascript is required for this survey to function, please enable through your browser settings, then refresh.